SavedAdd your journal

Journals / Kocaeli Tıp Dergisi / 2018 / Cilt: 7 - Sayı: 3

Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome

Polikistik Over Sendromlu Hastalarda Premenstrüel Disforik Bozukluk ve Affektif Mizaç

Halil İbrahim TAŞ
Başak ŞAHİN
Mehmet AŞIK
Yusuf Haydar ERTEKİN
Fatma BEYAZIT
Hülya ERTEKİN
Pages
118–123
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Considering and treating PMDD and other psychiatricconditions may increase the quality of life and functionality ofwomen with PCOS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION: This study aimed to evaluate the affectivetemperaments of women with Polycystic Ovary Syndrome(PCOS), to assess its comorbidity with PremenstrualDysphoric Disorder (PMDD) and compare with HealthyControls (HC).METHODS: A total of 20 women with PCOS and 20 HC wereincluded in this study.
📊
Key Findings & Data:The Diagnoses of PMDD and otherpsychiatric disorders were made by staff psychiatristsinterviewing all participants using DSM-5 diagnostic criteria.RESULTS: The comorbidity of PMDS in patients with PCOSwas 30% (n=6), while it was 15% (n=3) in the HC group.PMDS proportions did not differ significantly between groups.Patients with PCOS had higher major depression (25%, n=5)and anxiety disorders (20%, n=4) compared with HCs, butonly anxiety disorders were significantly higher in PCOS thanthe HC group (p=0.03).DISCUSSION and CONCLUSION: Patients with PCOS mayhave more comorbidity risk of PMDD, which is a mooddisorder according to DSM–5, and associated with menstrualcycles.
💡
Conclusion & Impact:Considering and treating PMDD and other psychiatricconditions may increase the quality of life and functionality ofwomen with PCOS.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

INTRODUCTION: This study aimed to evaluate the affectivetemperaments of women with Polycystic Ovary Syndrome(PCOS), to assess its comorbidity with PremenstrualDysphoric Disorder (PMDD) and compare with HealthyControls (HC).METHODS: A total of 20 women with PCOS and 20 HC wereincluded in this study. Hospital Anxiety and Depression Scale(HADS) and Temperament Evaluation of Memphis, Pisa, Parisand San Diego-Autoquestionnaire version (TEMPS-A) wereapplied to all participants. The Diagnoses of PMDD and otherpsychiatric disorders were made by staff psychiatristsinterviewing all participants using DSM-5 diagnostic criteria.RESULTS: The comorbidity of PMDS in patients with PCOSwas 30% (n=6), while it was 15% (n=3) in the HC group.PMDS proportions did not differ significantly between groups.Patients with PCOS had higher major depression (25%, n=5)and anxiety disorders (20%, n=4) compared with HCs, butonly anxiety disorders were significantly higher in PCOS thanthe HC group (p=0.03).DISCUSSION and CONCLUSION: Patients with PCOS mayhave more comorbidity risk of PMDD, which is a mooddisorder according to DSM–5, and associated with menstrualcycles. Considering and treating PMDD and other psychiatricconditions may increase the quality of life and functionality ofwomen with PCOS.

Özet

GİRİŞ ve AMAÇ: Bu çalışmada, Polikistik Over Sendromu (PKOS) olan kadınların, afektif mizaç özelliklerini ve Premenstrual Disforik Bozukluk (PMDB) komorbiditesini değerlendirmek ve Sağlıklı Kontrollerle (SK) karşılaştırmayı hedefledik. YÖNTEM ve GEREÇLER: Bu çalışmaya 20 PKOS hastası ve 20 SK dahil edildi. Tüm katılımcılara Hastane Anksiyete ve Depresyon Ölçeği (HADÖ) ve Mizaç Karakter Envanteri (Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire version (TEMPS-A)) uygulandı. PMDB ve diğer psikiyatrik bozuklukların tanıları, DSM-5 tanı ölçütlerini kullanarak tüm katılımcılarla bire bir görüşen uzman psikiyatristler tarafından yapıldı. BULGULAR: PKOS'lu hastalarda PMDB'nin eştanısı% 30 (n = 6) iken SK grubunda % 15 (n = 3) idi. PMDB oranları bakımından gruplar arasında anlamlı farklılık gözlenmedi. PKOS'lu hastalarda SK'lere göre daha yüksek oranda majör depresyon (% 25, n = 5) ve anksiyete bozukluğu (% 20, n = 4) olmakla birlikte, sadece anksiyete bozuklukları PKOS'da SK grubuna göre anlamlı derecede yüksekti (p = 0.03). TARTIŞMA ve SONUÇ: PKOS'lu hastalar, DSM-5’e göre duygudurum bozuklukları arasında olan ve adet döngüsü ile ilişkili olan PMDB komorbiditesi açısından risk faktörüne sahip olabilirler. PKOS’lu kadınlarda, PMDB ve diğer psikiyatrik durumları düşünmek ve tedavi etmek, bu hastaların yaşam kalitesini ve işlevselliğini artırabilir.

🔖

Cite This Article

TAŞ, H. İ., ŞAHİN, B., AŞIK, M., ERTEKİN, Y. H., BEYAZIT, F., ERTEKİN, H. (2022). Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. Kocaeli Tıp Dergisi, Cilt: 7 - Sayı: 3, 118–123. https://ajindex.com/articles/574878

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;11:1223–36
  2. Li Y, Li Y, Yu Ng EH, Stener-Victorin E, Hou L, Wu T, et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril 2011;96: 452–8
  3. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005;11:853–60
  4. Setji, TL, Brown AJ. Polycystic ovary syndrome: update on diagnosis and treatment. Am J Med 2014;127:912–9
  5. Davari-Tanha F, Hosseini Rashidi B, Ghajarzadeh M, Noorbala AA. Bipolar disorder in women with polycystic ovarian syndrome (PCOS). Acta Med Iran 2014;52(1):46–8
  6. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009;91(1):207–12
  7. Bhattacharya SM, Jha A. Prevalence and risk of depressive disorder in women with polycystic ovary syndrome (PCOS). Fertil Steril 2010;94:357– 9
  8. Jedel E, Waern M, Gustafson D, Landén M, Eriksson E, Holm G, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum Reprod 2010;25(2):450-6
  9. Naqvi SH, Moore A, Bevilacqua K, Lathief S, Williams J, Naqvi N, et al. Predictors of depression in women with polycystic ovary syndrome. Arch Womens Ment Health 2015;18:95– 101
  10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013
  11. Nevatte T, O 'Brien PM, Backstrom T, Brown C, Dennerstein L, Endicott J, et al. Is PMD consensus on the management of premenstrual disorders. Arch Women Ment Health 2013;1 6:279 -91
  12. Yonkers KA, O'Brien PM, Eriksson E. Premenstrual syndrome. Lancet 2008;371: 1200 - 1210
  13. Akiskal HS, Akiskal KK, Haykal RF, Manning JS, Connor PD. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J Affect Disord 2005; 85;3 – 16. 14. de Aguiar Ferreira A, Vasconcelos AG, Neves FS, Correa H. Affective temperaments and antidepressant response in the clinical management of mood disorders J Affect Disord 2014; 155:138– 41
  14. Kesebir A, Gundogar D, Kucuksubas Y, Tatlıdil Yaylacı E. The relation be